....I went back to my records on director Lekkas' buying.
Excluding the 20m he was issued as start up (deemed cost of $140k), he has paid from his own pocket a total of $299,833.66 for 31.5m shares. Last purchase 25/05/11. Has not reported any sales. For the record, he was not given any 1c options either.
Hanging in there, initial assay results can't be far off.
Add to My Watchlist
What is My Watchlist?